nodes	percent_of_prediction	percent_of_DWPC	metapath
Sparfloxacin—ABCB1—melanoma	0.343	1	CbGaD
Sparfloxacin—SLC22A5—Dactinomycin—melanoma	0.236	0.56	CbGbCtD
Sparfloxacin—ABCC2—Docetaxel—melanoma	0.095	0.225	CbGbCtD
Sparfloxacin—ABCB1—Dactinomycin—melanoma	0.06	0.142	CbGbCtD
Sparfloxacin—ABCB1—Docetaxel—melanoma	0.031	0.0733	CbGbCtD
Sparfloxacin—TOP2A—Paclitaxel—Docetaxel—melanoma	0.0037	1	CbGdCrCtD
Sparfloxacin—Pancytopenia—Carmustine—melanoma	0.000526	0.00279	CcSEcCtD
Sparfloxacin—Stevens-Johnson syndrome—Dactinomycin—melanoma	0.000523	0.00277	CcSEcCtD
Sparfloxacin—Decreased appetite—Vemurafenib—melanoma	0.000517	0.00275	CcSEcCtD
Sparfloxacin—Bronchitis—Temozolomide—melanoma	0.000514	0.00273	CcSEcCtD
Sparfloxacin—Stomatitis—Dactinomycin—melanoma	0.000514	0.00273	CcSEcCtD
Sparfloxacin—Haemoglobin—Bleomycin—melanoma	0.00051	0.00271	CcSEcCtD
Sparfloxacin—Constipation—Vemurafenib—melanoma	0.000509	0.0027	CcSEcCtD
Sparfloxacin—Pancytopenia—Temozolomide—melanoma	0.000508	0.0027	CcSEcCtD
Sparfloxacin—Haemorrhage—Bleomycin—melanoma	0.000507	0.00269	CcSEcCtD
Sparfloxacin—Lightheadedness—Docetaxel—melanoma	0.000507	0.00269	CcSEcCtD
Sparfloxacin—Hypoaesthesia—Bleomycin—melanoma	0.000505	0.00268	CcSEcCtD
Sparfloxacin—Pulmonary oedema—Docetaxel—melanoma	0.000505	0.00268	CcSEcCtD
Sparfloxacin—Dysuria—Temozolomide—melanoma	0.0005	0.00265	CcSEcCtD
Sparfloxacin—Pneumonia—Carmustine—melanoma	0.000496	0.00263	CcSEcCtD
Sparfloxacin—Agranulocytosis—Dactinomycin—melanoma	0.000492	0.00261	CcSEcCtD
Sparfloxacin—Photosensitivity reaction—Temozolomide—melanoma	0.000488	0.00259	CcSEcCtD
Sparfloxacin—Stomatitis—Carmustine—melanoma	0.000481	0.00255	CcSEcCtD
Sparfloxacin—Urinary tract infection—Carmustine—melanoma	0.00048	0.00255	CcSEcCtD
Sparfloxacin—Pneumonia—Temozolomide—melanoma	0.00048	0.00255	CcSEcCtD
Sparfloxacin—Hepatitis—Dactinomycin—melanoma	0.000473	0.00251	CcSEcCtD
Sparfloxacin—Stevens-Johnson syndrome—Temozolomide—melanoma	0.000473	0.00251	CcSEcCtD
Sparfloxacin—Body temperature increased—Vemurafenib—melanoma	0.00047	0.0025	CcSEcCtD
Sparfloxacin—Pharyngitis—Dactinomycin—melanoma	0.00047	0.00249	CcSEcCtD
Sparfloxacin—Stomatitis—Temozolomide—melanoma	0.000465	0.00247	CcSEcCtD
Sparfloxacin—Urinary tract infection—Temozolomide—melanoma	0.000464	0.00246	CcSEcCtD
Sparfloxacin—Hepatic failure—Docetaxel—melanoma	0.000458	0.00243	CcSEcCtD
Sparfloxacin—Chills—Bleomycin—melanoma	0.000455	0.00242	CcSEcCtD
Sparfloxacin—Alopecia—Bleomycin—melanoma	0.000448	0.00238	CcSEcCtD
Sparfloxacin—Erythema multiforme—Dactinomycin—melanoma	0.000448	0.00238	CcSEcCtD
Sparfloxacin—Sinusitis—Temozolomide—melanoma	0.000447	0.00237	CcSEcCtD
Sparfloxacin—Haemoglobin—Carmustine—melanoma	0.000445	0.00236	CcSEcCtD
Sparfloxacin—Haemorrhage—Carmustine—melanoma	0.000443	0.00235	CcSEcCtD
Sparfloxacin—Hypoaesthesia—Carmustine—melanoma	0.000441	0.00234	CcSEcCtD
Sparfloxacin—Hallucination—Carmustine—melanoma	0.000441	0.00234	CcSEcCtD
Sparfloxacin—Hypersensitivity—Vemurafenib—melanoma	0.000438	0.00233	CcSEcCtD
Sparfloxacin—Oedema peripheral—Carmustine—melanoma	0.000436	0.00232	CcSEcCtD
Sparfloxacin—Atrial fibrillation—Docetaxel—melanoma	0.000434	0.00231	CcSEcCtD
Sparfloxacin—Dermatitis bullous—Docetaxel—melanoma	0.000431	0.00229	CcSEcCtD
Sparfloxacin—Haemoglobin—Temozolomide—melanoma	0.00043	0.00228	CcSEcCtD
Sparfloxacin—Hepatitis—Temozolomide—melanoma	0.000428	0.00227	CcSEcCtD
Sparfloxacin—Haemorrhage—Temozolomide—melanoma	0.000428	0.00227	CcSEcCtD
Sparfloxacin—Asthenia—Vemurafenib—melanoma	0.000427	0.00227	CcSEcCtD
Sparfloxacin—Hypoaesthesia—Temozolomide—melanoma	0.000426	0.00226	CcSEcCtD
Sparfloxacin—Hallucination—Temozolomide—melanoma	0.000426	0.00226	CcSEcCtD
Sparfloxacin—Pharyngitis—Temozolomide—melanoma	0.000425	0.00226	CcSEcCtD
Sparfloxacin—Chills—Dactinomycin—melanoma	0.000425	0.00225	CcSEcCtD
Sparfloxacin—Oedema peripheral—Temozolomide—melanoma	0.000422	0.00224	CcSEcCtD
Sparfloxacin—Pruritus—Vemurafenib—melanoma	0.000421	0.00223	CcSEcCtD
Sparfloxacin—Alopecia—Dactinomycin—melanoma	0.000418	0.00222	CcSEcCtD
Sparfloxacin—Gatifloxacin—ALB—melanoma	0.000412	0.537	CrCbGaD
Sparfloxacin—Ill-defined disorder—Bleomycin—melanoma	0.00041	0.00218	CcSEcCtD
Sparfloxacin—Diarrhoea—Vemurafenib—melanoma	0.000407	0.00216	CcSEcCtD
Sparfloxacin—Migraine—Docetaxel—melanoma	0.000405	0.00215	CcSEcCtD
Sparfloxacin—Erythema multiforme—Temozolomide—melanoma	0.000405	0.00215	CcSEcCtD
Sparfloxacin—Tinnitus—Temozolomide—melanoma	0.000399	0.00212	CcSEcCtD
Sparfloxacin—Malaise—Bleomycin—melanoma	0.000398	0.00211	CcSEcCtD
Sparfloxacin—Arrhythmia—Carmustine—melanoma	0.000396	0.0021	CcSEcCtD
Sparfloxacin—Dizziness—Vemurafenib—melanoma	0.000394	0.00209	CcSEcCtD
Sparfloxacin—Alopecia—Carmustine—melanoma	0.000391	0.00208	CcSEcCtD
Sparfloxacin—Ataxia—Docetaxel—melanoma	0.000387	0.00205	CcSEcCtD
Sparfloxacin—Cough—Bleomycin—melanoma	0.000386	0.00205	CcSEcCtD
Sparfloxacin—Chills—Temozolomide—melanoma	0.000384	0.00204	CcSEcCtD
Sparfloxacin—Ill-defined disorder—Dactinomycin—melanoma	0.000382	0.00203	CcSEcCtD
Sparfloxacin—Vomiting—Vemurafenib—melanoma	0.000378	0.00201	CcSEcCtD
Sparfloxacin—Alopecia—Temozolomide—melanoma	0.000378	0.00201	CcSEcCtD
Sparfloxacin—Dry skin—Docetaxel—melanoma	0.000377	0.002	CcSEcCtD
Sparfloxacin—Chest pain—Bleomycin—melanoma	0.000376	0.002	CcSEcCtD
Sparfloxacin—Myalgia—Bleomycin—melanoma	0.000376	0.002	CcSEcCtD
Sparfloxacin—Orthostatic hypotension—Docetaxel—melanoma	0.000376	0.002	CcSEcCtD
Sparfloxacin—Abdominal pain upper—Docetaxel—melanoma	0.000376	0.002	CcSEcCtD
Sparfloxacin—Rash—Vemurafenib—melanoma	0.000375	0.00199	CcSEcCtD
Sparfloxacin—Dermatitis—Vemurafenib—melanoma	0.000375	0.00199	CcSEcCtD
Sparfloxacin—Back pain—Carmustine—melanoma	0.000373	0.00198	CcSEcCtD
Sparfloxacin—Headache—Vemurafenib—melanoma	0.000373	0.00198	CcSEcCtD
Sparfloxacin—Discomfort—Bleomycin—melanoma	0.000372	0.00197	CcSEcCtD
Sparfloxacin—Malaise—Dactinomycin—melanoma	0.000372	0.00197	CcSEcCtD
Sparfloxacin—Toxic epidermal necrolysis—Docetaxel—melanoma	0.000371	0.00197	CcSEcCtD
Sparfloxacin—Dysgeusia—Temozolomide—melanoma	0.000365	0.00194	CcSEcCtD
Sparfloxacin—Confusional state—Bleomycin—melanoma	0.000364	0.00193	CcSEcCtD
Sparfloxacin—Alanine aminotransferase increased—Docetaxel—melanoma	0.000363	0.00193	CcSEcCtD
Sparfloxacin—Tremor—Carmustine—melanoma	0.000361	0.00192	CcSEcCtD
Sparfloxacin—Anaphylactic shock—Bleomycin—melanoma	0.000361	0.00191	CcSEcCtD
Sparfloxacin—Back pain—Temozolomide—melanoma	0.00036	0.00191	CcSEcCtD
Sparfloxacin—Agitation—Carmustine—melanoma	0.000354	0.00188	CcSEcCtD
Sparfloxacin—Nausea—Vemurafenib—melanoma	0.000353	0.00188	CcSEcCtD
Sparfloxacin—Thrombocytopenia—Bleomycin—melanoma	0.000353	0.00187	CcSEcCtD
Sparfloxacin—Myalgia—Dactinomycin—melanoma	0.000351	0.00186	CcSEcCtD
Sparfloxacin—Tremor—Temozolomide—melanoma	0.000349	0.00185	CcSEcCtD
Sparfloxacin—Discomfort—Dactinomycin—melanoma	0.000347	0.00184	CcSEcCtD
Sparfloxacin—Angina pectoris—Docetaxel—melanoma	0.000346	0.00184	CcSEcCtD
Sparfloxacin—Ill-defined disorder—Temozolomide—melanoma	0.000346	0.00184	CcSEcCtD
Sparfloxacin—Anorexia—Bleomycin—melanoma	0.000344	0.00182	CcSEcCtD
Sparfloxacin—Agitation—Temozolomide—melanoma	0.000342	0.00182	CcSEcCtD
Sparfloxacin—Angioedema—Temozolomide—melanoma	0.000341	0.00181	CcSEcCtD
Sparfloxacin—Pancytopenia—Docetaxel—melanoma	0.000338	0.00179	CcSEcCtD
Sparfloxacin—Malaise—Temozolomide—melanoma	0.000336	0.00178	CcSEcCtD
Sparfloxacin—Vertigo—Temozolomide—melanoma	0.000335	0.00178	CcSEcCtD
Sparfloxacin—Convulsion—Carmustine—melanoma	0.000334	0.00177	CcSEcCtD
Sparfloxacin—Hypertension—Carmustine—melanoma	0.000333	0.00177	CcSEcCtD
Sparfloxacin—Palpitations—Temozolomide—melanoma	0.000329	0.00175	CcSEcCtD
Sparfloxacin—Thrombocytopenia—Dactinomycin—melanoma	0.000329	0.00175	CcSEcCtD
Sparfloxacin—Musculoskeletal discomfort—Bleomycin—melanoma	0.000328	0.00174	CcSEcCtD
Sparfloxacin—Chest pain—Carmustine—melanoma	0.000328	0.00174	CcSEcCtD
Sparfloxacin—Myalgia—Carmustine—melanoma	0.000328	0.00174	CcSEcCtD
Sparfloxacin—Anxiety—Carmustine—melanoma	0.000327	0.00174	CcSEcCtD
Sparfloxacin—Cough—Temozolomide—melanoma	0.000325	0.00173	CcSEcCtD
Sparfloxacin—Paraesthesia—Bleomycin—melanoma	0.000324	0.00172	CcSEcCtD
Sparfloxacin—Convulsion—Temozolomide—melanoma	0.000323	0.00171	CcSEcCtD
Sparfloxacin—Hypertension—Temozolomide—melanoma	0.000322	0.00171	CcSEcCtD
Sparfloxacin—Dyspnoea—Bleomycin—melanoma	0.000321	0.00171	CcSEcCtD
Sparfloxacin—Anorexia—Dactinomycin—melanoma	0.000321	0.0017	CcSEcCtD
Sparfloxacin—Pneumonia—Docetaxel—melanoma	0.000319	0.00169	CcSEcCtD
Sparfloxacin—Confusional state—Carmustine—melanoma	0.000317	0.00168	CcSEcCtD
Sparfloxacin—Arthralgia—Temozolomide—melanoma	0.000317	0.00168	CcSEcCtD
Sparfloxacin—Myalgia—Temozolomide—melanoma	0.000317	0.00168	CcSEcCtD
Sparfloxacin—Anxiety—Temozolomide—melanoma	0.000316	0.00168	CcSEcCtD
Sparfloxacin—Stevens-Johnson syndrome—Docetaxel—melanoma	0.000314	0.00167	CcSEcCtD
Sparfloxacin—Discomfort—Temozolomide—melanoma	0.000313	0.00166	CcSEcCtD
Sparfloxacin—Decreased appetite—Bleomycin—melanoma	0.000313	0.00166	CcSEcCtD
Sparfloxacin—Dry mouth—Temozolomide—melanoma	0.00031	0.00165	CcSEcCtD
Sparfloxacin—Stomatitis—Docetaxel—melanoma	0.000309	0.00164	CcSEcCtD
Sparfloxacin—Jaundice—Docetaxel—melanoma	0.000309	0.00164	CcSEcCtD
Sparfloxacin—Pain—Bleomycin—melanoma	0.000308	0.00164	CcSEcCtD
Sparfloxacin—Conjunctivitis—Docetaxel—melanoma	0.000308	0.00164	CcSEcCtD
Sparfloxacin—Thrombocytopenia—Carmustine—melanoma	0.000308	0.00164	CcSEcCtD
Sparfloxacin—Tachycardia—Carmustine—melanoma	0.000307	0.00163	CcSEcCtD
Sparfloxacin—Confusional state—Temozolomide—melanoma	0.000307	0.00163	CcSEcCtD
Sparfloxacin—Musculoskeletal discomfort—Dactinomycin—melanoma	0.000306	0.00163	CcSEcCtD
Sparfloxacin—Anaphylactic shock—Temozolomide—melanoma	0.000304	0.00161	CcSEcCtD
Sparfloxacin—Anorexia—Carmustine—melanoma	0.0003	0.00159	CcSEcCtD
Sparfloxacin—Epistaxis—Docetaxel—melanoma	0.000299	0.00159	CcSEcCtD
Sparfloxacin—Thrombocytopenia—Temozolomide—melanoma	0.000298	0.00158	CcSEcCtD
Sparfloxacin—Feeling abnormal—Bleomycin—melanoma	0.000297	0.00158	CcSEcCtD
Sparfloxacin—Agranulocytosis—Docetaxel—melanoma	0.000296	0.00157	CcSEcCtD
Sparfloxacin—Hyperhidrosis—Temozolomide—melanoma	0.000294	0.00156	CcSEcCtD
Sparfloxacin—Decreased appetite—Dactinomycin—melanoma	0.000292	0.00155	CcSEcCtD
Sparfloxacin—Anorexia—Temozolomide—melanoma	0.00029	0.00154	CcSEcCtD
Sparfloxacin—Pain—Dactinomycin—melanoma	0.000288	0.00153	CcSEcCtD
Sparfloxacin—Musculoskeletal discomfort—Carmustine—melanoma	0.000287	0.00152	CcSEcCtD
Sparfloxacin—Urticaria—Bleomycin—melanoma	0.000286	0.00152	CcSEcCtD
Sparfloxacin—Haemoglobin—Docetaxel—melanoma	0.000286	0.00152	CcSEcCtD
Sparfloxacin—Rhinitis—Docetaxel—melanoma	0.000285	0.00152	CcSEcCtD
Sparfloxacin—Body temperature increased—Bleomycin—melanoma	0.000285	0.00151	CcSEcCtD
Sparfloxacin—Haemorrhage—Docetaxel—melanoma	0.000285	0.00151	CcSEcCtD
Sparfloxacin—Hepatitis—Docetaxel—melanoma	0.000285	0.00151	CcSEcCtD
Sparfloxacin—Insomnia—Carmustine—melanoma	0.000285	0.00151	CcSEcCtD
Sparfloxacin—Hypoaesthesia—Docetaxel—melanoma	0.000283	0.0015	CcSEcCtD
Sparfloxacin—Paraesthesia—Carmustine—melanoma	0.000283	0.0015	CcSEcCtD
Sparfloxacin—Pharyngitis—Docetaxel—melanoma	0.000283	0.0015	CcSEcCtD
Sparfloxacin—Dyspnoea—Carmustine—melanoma	0.000281	0.00149	CcSEcCtD
Sparfloxacin—Oedema peripheral—Docetaxel—melanoma	0.00028	0.00149	CcSEcCtD
Sparfloxacin—Somnolence—Carmustine—melanoma	0.00028	0.00149	CcSEcCtD
Sparfloxacin—Feeling abnormal—Dactinomycin—melanoma	0.000277	0.00147	CcSEcCtD
Sparfloxacin—Musculoskeletal discomfort—Temozolomide—melanoma	0.000277	0.00147	CcSEcCtD
Sparfloxacin—Insomnia—Temozolomide—melanoma	0.000275	0.00146	CcSEcCtD
Sparfloxacin—Gastrointestinal pain—Dactinomycin—melanoma	0.000275	0.00146	CcSEcCtD
Sparfloxacin—Decreased appetite—Carmustine—melanoma	0.000274	0.00145	CcSEcCtD
Sparfloxacin—Paraesthesia—Temozolomide—melanoma	0.000273	0.00145	CcSEcCtD
Sparfloxacin—Dyspnoea—Temozolomide—melanoma	0.000271	0.00144	CcSEcCtD
Sparfloxacin—Somnolence—Temozolomide—melanoma	0.00027	0.00144	CcSEcCtD
Sparfloxacin—Erythema multiforme—Docetaxel—melanoma	0.000269	0.00143	CcSEcCtD
Sparfloxacin—Pain—Carmustine—melanoma	0.000269	0.00143	CcSEcCtD
Sparfloxacin—Constipation—Carmustine—melanoma	0.000269	0.00143	CcSEcCtD
Sparfloxacin—Dyspepsia—Temozolomide—melanoma	0.000268	0.00142	CcSEcCtD
Sparfloxacin—Abdominal pain—Dactinomycin—melanoma	0.000266	0.00141	CcSEcCtD
Sparfloxacin—Body temperature increased—Dactinomycin—melanoma	0.000266	0.00141	CcSEcCtD
Sparfloxacin—Hypersensitivity—Bleomycin—melanoma	0.000266	0.00141	CcSEcCtD
Sparfloxacin—Decreased appetite—Temozolomide—melanoma	0.000264	0.0014	CcSEcCtD
Sparfloxacin—Pain—Temozolomide—melanoma	0.00026	0.00138	CcSEcCtD
Sparfloxacin—Constipation—Temozolomide—melanoma	0.00026	0.00138	CcSEcCtD
Sparfloxacin—Feeling abnormal—Carmustine—melanoma	0.000259	0.00138	CcSEcCtD
Sparfloxacin—Asthenia—Bleomycin—melanoma	0.000259	0.00137	CcSEcCtD
Sparfloxacin—Gastrointestinal pain—Carmustine—melanoma	0.000257	0.00137	CcSEcCtD
Sparfloxacin—Chills—Docetaxel—melanoma	0.000255	0.00136	CcSEcCtD
Sparfloxacin—Pruritus—Bleomycin—melanoma	0.000255	0.00135	CcSEcCtD
Sparfloxacin—Arrhythmia—Docetaxel—melanoma	0.000254	0.00135	CcSEcCtD
Sparfloxacin—Alopecia—Docetaxel—melanoma	0.000252	0.00134	CcSEcCtD
Sparfloxacin—Feeling abnormal—Temozolomide—melanoma	0.000251	0.00133	CcSEcCtD
Sparfloxacin—Abdominal pain—Carmustine—melanoma	0.000249	0.00132	CcSEcCtD
Sparfloxacin—Body temperature increased—Carmustine—melanoma	0.000249	0.00132	CcSEcCtD
Sparfloxacin—Gastrointestinal pain—Temozolomide—melanoma	0.000249	0.00132	CcSEcCtD
Sparfloxacin—Hypersensitivity—Dactinomycin—melanoma	0.000248	0.00132	CcSEcCtD
Sparfloxacin—Dysgeusia—Docetaxel—melanoma	0.000243	0.00129	CcSEcCtD
Sparfloxacin—Urticaria—Temozolomide—melanoma	0.000242	0.00128	CcSEcCtD
Sparfloxacin—Asthenia—Dactinomycin—melanoma	0.000241	0.00128	CcSEcCtD
Sparfloxacin—Abdominal pain—Temozolomide—melanoma	0.00024	0.00128	CcSEcCtD
Sparfloxacin—Body temperature increased—Temozolomide—melanoma	0.00024	0.00128	CcSEcCtD
Sparfloxacin—Back pain—Docetaxel—melanoma	0.00024	0.00127	CcSEcCtD
Sparfloxacin—Hypersensitivity—Carmustine—melanoma	0.000232	0.00123	CcSEcCtD
Sparfloxacin—Diarrhoea—Dactinomycin—melanoma	0.00023	0.00122	CcSEcCtD
Sparfloxacin—Vomiting—Bleomycin—melanoma	0.000229	0.00122	CcSEcCtD
Sparfloxacin—Rash—Bleomycin—melanoma	0.000227	0.00121	CcSEcCtD
Sparfloxacin—Dermatitis—Bleomycin—melanoma	0.000227	0.00121	CcSEcCtD
Sparfloxacin—Asthenia—Carmustine—melanoma	0.000226	0.0012	CcSEcCtD
Sparfloxacin—Hypersensitivity—Temozolomide—melanoma	0.000224	0.00119	CcSEcCtD
Sparfloxacin—Palpitations—Docetaxel—melanoma	0.000219	0.00116	CcSEcCtD
Sparfloxacin—Asthenia—Temozolomide—melanoma	0.000218	0.00116	CcSEcCtD
Sparfloxacin—Cough—Docetaxel—melanoma	0.000216	0.00115	CcSEcCtD
Sparfloxacin—Diarrhoea—Carmustine—melanoma	0.000215	0.00114	CcSEcCtD
Sparfloxacin—Pruritus—Temozolomide—melanoma	0.000215	0.00114	CcSEcCtD
Sparfloxacin—Convulsion—Docetaxel—melanoma	0.000215	0.00114	CcSEcCtD
Sparfloxacin—Nausea—Bleomycin—melanoma	0.000214	0.00114	CcSEcCtD
Sparfloxacin—Hypertension—Docetaxel—melanoma	0.000214	0.00114	CcSEcCtD
Sparfloxacin—Vomiting—Dactinomycin—melanoma	0.000214	0.00113	CcSEcCtD
Sparfloxacin—Rash—Dactinomycin—melanoma	0.000212	0.00113	CcSEcCtD
Sparfloxacin—Chest pain—Docetaxel—melanoma	0.000211	0.00112	CcSEcCtD
Sparfloxacin—Arthralgia—Docetaxel—melanoma	0.000211	0.00112	CcSEcCtD
Sparfloxacin—Myalgia—Docetaxel—melanoma	0.000211	0.00112	CcSEcCtD
Sparfloxacin—Dizziness—Carmustine—melanoma	0.000208	0.0011	CcSEcCtD
Sparfloxacin—Diarrhoea—Temozolomide—melanoma	0.000208	0.0011	CcSEcCtD
Sparfloxacin—Dry mouth—Docetaxel—melanoma	0.000206	0.0011	CcSEcCtD
Sparfloxacin—Confusional state—Docetaxel—melanoma	0.000204	0.00108	CcSEcCtD
Sparfloxacin—Anaphylactic shock—Docetaxel—melanoma	0.000202	0.00107	CcSEcCtD
Sparfloxacin—Dizziness—Temozolomide—melanoma	0.000201	0.00107	CcSEcCtD
Sparfloxacin—Vomiting—Carmustine—melanoma	0.0002	0.00106	CcSEcCtD
Sparfloxacin—Nausea—Dactinomycin—melanoma	0.0002	0.00106	CcSEcCtD
Sparfloxacin—Rash—Carmustine—melanoma	0.000198	0.00105	CcSEcCtD
Sparfloxacin—Dermatitis—Carmustine—melanoma	0.000198	0.00105	CcSEcCtD
Sparfloxacin—Thrombocytopenia—Docetaxel—melanoma	0.000198	0.00105	CcSEcCtD
Sparfloxacin—Tachycardia—Docetaxel—melanoma	0.000197	0.00105	CcSEcCtD
Sparfloxacin—Headache—Carmustine—melanoma	0.000197	0.00105	CcSEcCtD
Sparfloxacin—Vomiting—Temozolomide—melanoma	0.000193	0.00103	CcSEcCtD
Sparfloxacin—Anorexia—Docetaxel—melanoma	0.000193	0.00102	CcSEcCtD
Sparfloxacin—Rash—Temozolomide—melanoma	0.000192	0.00102	CcSEcCtD
Sparfloxacin—Dermatitis—Temozolomide—melanoma	0.000192	0.00102	CcSEcCtD
Sparfloxacin—Headache—Temozolomide—melanoma	0.000191	0.00101	CcSEcCtD
Sparfloxacin—Nausea—Carmustine—melanoma	0.000187	0.000992	CcSEcCtD
Sparfloxacin—Musculoskeletal discomfort—Docetaxel—melanoma	0.000184	0.000978	CcSEcCtD
Sparfloxacin—Insomnia—Docetaxel—melanoma	0.000183	0.000971	CcSEcCtD
Sparfloxacin—Paraesthesia—Docetaxel—melanoma	0.000182	0.000964	CcSEcCtD
Sparfloxacin—Levofloxacin—ABCB1—melanoma	0.000181	0.235	CrCbGaD
Sparfloxacin—Nausea—Temozolomide—melanoma	0.000181	0.000959	CcSEcCtD
Sparfloxacin—Dyspnoea—Docetaxel—melanoma	0.00018	0.000957	CcSEcCtD
Sparfloxacin—Somnolence—Docetaxel—melanoma	0.00018	0.000954	CcSEcCtD
Sparfloxacin—Dyspepsia—Docetaxel—melanoma	0.000178	0.000945	CcSEcCtD
Sparfloxacin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—FLT1—melanoma	0.000176	0.00418	CbGpPWpGaD
Sparfloxacin—Decreased appetite—Docetaxel—melanoma	0.000176	0.000933	CcSEcCtD
Sparfloxacin—Ciprofloxacin—ABCB1—melanoma	0.000175	0.227	CrCbGaD
Sparfloxacin—TOP2A—Circadian rythm related genes—GNA11—melanoma	0.000174	0.00412	CbGpPWpGaD
Sparfloxacin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—melanoma	0.000174	0.00412	CbGpPWpGaD
Sparfloxacin—Pain—Docetaxel—melanoma	0.000173	0.000918	CcSEcCtD
Sparfloxacin—Constipation—Docetaxel—melanoma	0.000173	0.000918	CcSEcCtD
Sparfloxacin—TOP2A—Cell Cycle—INCENP—melanoma	0.00017	0.00403	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle—PKMYT1—melanoma	0.00017	0.00403	CbGpPWpGaD
Sparfloxacin—Feeling abnormal—Docetaxel—melanoma	0.000167	0.000885	CcSEcCtD
Sparfloxacin—TOP2A—Retinoblastoma (RB) in Cancer—RB1—melanoma	0.000166	0.00394	CbGpPWpGaD
Sparfloxacin—SLC22A5—Transmembrane transport of small molecules—SLC15A2—melanoma	0.000166	0.00393	CbGpPWpGaD
Sparfloxacin—Gastrointestinal pain—Docetaxel—melanoma	0.000165	0.000878	CcSEcCtD
Sparfloxacin—TOP2A—Mitotic G1-G1/S phases—E2F1—melanoma	0.000165	0.00391	CbGpPWpGaD
Sparfloxacin—TOP2A—Circadian rythm related genes—HDAC2—melanoma	0.000164	0.00387	CbGpPWpGaD
Sparfloxacin—TOP2A—Circadian rythm related genes—GNAQ—melanoma	0.000162	0.00383	CbGpPWpGaD
Sparfloxacin—ABCB1—Allograft Rejection—FOXP3—melanoma	0.000161	0.00381	CbGpPWpGaD
Sparfloxacin—ABCC2—Transmembrane transport of small molecules—ARL2—melanoma	0.00016	0.00379	CbGpPWpGaD
Sparfloxacin—ABCB1—HIF-1-alpha transcription factor network—ETS1—melanoma	0.00016	0.00379	CbGpPWpGaD
Sparfloxacin—Body temperature increased—Docetaxel—melanoma	0.00016	0.000849	CcSEcCtD
Sparfloxacin—Abdominal pain—Docetaxel—melanoma	0.00016	0.000849	CcSEcCtD
Sparfloxacin—SLC22A5—Transmembrane transport of small molecules—SLC17A5—melanoma	0.00016	0.00378	CbGpPWpGaD
Sparfloxacin—TOP2A—Mitotic G1-G1/S phases—PCNA—melanoma	0.000156	0.00368	CbGpPWpGaD
Sparfloxacin—ABCC2—NRF2 pathway—SLC5A5—melanoma	0.000151	0.00359	CbGpPWpGaD
Sparfloxacin—TOP2A—Circadian rythm related genes—NGFR—melanoma	0.000149	0.00354	CbGpPWpGaD
Sparfloxacin—Hypersensitivity—Docetaxel—melanoma	0.000149	0.000791	CcSEcCtD
Sparfloxacin—Asthenia—Docetaxel—melanoma	0.000145	0.00077	CcSEcCtD
Sparfloxacin—SLC22A5—Transmembrane transport of small molecules—SLC6A11—melanoma	0.000145	0.00344	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle—POT1—melanoma	0.000143	0.00339	CbGpPWpGaD
Sparfloxacin—Pruritus—Docetaxel—melanoma	0.000143	0.00076	CcSEcCtD
Sparfloxacin—TOP2A—Mitotic G1-G1/S phases—CDK2—melanoma	0.000142	0.00337	CbGpPWpGaD
Sparfloxacin—TOP2A—Retinoblastoma (RB) in Cancer—MDM2—melanoma	0.000142	0.00336	CbGpPWpGaD
Sparfloxacin—ABCB1—HIF-1-alpha transcription factor network—EPO—melanoma	0.000141	0.00334	CbGpPWpGaD
Sparfloxacin—Diarrhoea—Docetaxel—melanoma	0.000138	0.000735	CcSEcCtD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CDKN2B—melanoma	0.000136	0.00322	CbGpPWpGaD
Sparfloxacin—TOP2A—Mitotic G1-G1/S phases—CDK4—melanoma	0.000134	0.00318	CbGpPWpGaD
Sparfloxacin—Dizziness—Docetaxel—melanoma	0.000134	0.00071	CcSEcCtD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—ABCB1—melanoma	0.000133	0.00315	CbGpPWpGaD
Sparfloxacin—ABCB1—HIF-1-alpha transcription factor network—CXCR4—melanoma	0.000131	0.00311	CbGpPWpGaD
Sparfloxacin—SLC22A5—SLC-mediated transmembrane transport—SLC5A5—melanoma	0.000131	0.00309	CbGpPWpGaD
Sparfloxacin—TOP2A—Retinoblastoma (RB) in Cancer—CDKN1B—melanoma	0.000129	0.00306	CbGpPWpGaD
Sparfloxacin—Vomiting—Docetaxel—melanoma	0.000129	0.000683	CcSEcCtD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—FGF1—melanoma	0.000128	0.00302	CbGpPWpGaD
Sparfloxacin—Rash—Docetaxel—melanoma	0.000128	0.000677	CcSEcCtD
Sparfloxacin—Dermatitis—Docetaxel—melanoma	0.000127	0.000676	CcSEcCtD
Sparfloxacin—Headache—Docetaxel—melanoma	0.000127	0.000673	CcSEcCtD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—CAPN1—melanoma	0.000126	0.00298	CbGpPWpGaD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—E2F1—melanoma	0.000125	0.00296	CbGpPWpGaD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PDGFRA—melanoma	0.000124	0.00293	CbGpPWpGaD
Sparfloxacin—TOP2A—Retinoblastoma (RB) in Cancer—CCND1—melanoma	0.000123	0.00292	CbGpPWpGaD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PRKCA—melanoma	0.000122	0.0029	CbGpPWpGaD
Sparfloxacin—ABCC2—Transmembrane transport of small molecules—SLC15A2—melanoma	0.000121	0.00287	CbGpPWpGaD
Sparfloxacin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—melanoma	0.000121	0.00287	CbGpPWpGaD
Sparfloxacin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRA—melanoma	0.000121	0.00286	CbGpPWpGaD
Sparfloxacin—Nausea—Docetaxel—melanoma	0.00012	0.000638	CcSEcCtD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—FASLG—melanoma	0.00012	0.00284	CbGpPWpGaD
Sparfloxacin—TOP2A—Retinoblastoma (RB) in Cancer—CDKN1A—melanoma	0.000119	0.00283	CbGpPWpGaD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PCNA—melanoma	0.000118	0.00279	CbGpPWpGaD
Sparfloxacin—TOP2A—Mitotic G1-G1/S phases—RB1—melanoma	0.000117	0.00277	CbGpPWpGaD
Sparfloxacin—ABCC2—Transmembrane transport of small molecules—SLC17A5—melanoma	0.000117	0.00277	CbGpPWpGaD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—FAS—melanoma	0.000116	0.00274	CbGpPWpGaD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—RAC1—melanoma	0.000113	0.00269	CbGpPWpGaD
Sparfloxacin—ABCC2—NRF2 pathway—HGF—melanoma	0.000112	0.00266	CbGpPWpGaD
Sparfloxacin—TOP2A—Circadian rythm related genes—FAS—melanoma	0.000111	0.00263	CbGpPWpGaD
Sparfloxacin—ABCB1—Allograft Rejection—CTLA4—melanoma	0.000111	0.00262	CbGpPWpGaD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—ABCB5—melanoma	0.000109	0.00257	CbGpPWpGaD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CDK2—melanoma	0.000108	0.00255	CbGpPWpGaD
Sparfloxacin—ABCC2—Transmembrane transport of small molecules—SLC6A11—melanoma	0.000106	0.00251	CbGpPWpGaD
Sparfloxacin—TOP2A—Mitotic G1-G1/S phases—CDKN2A—melanoma	0.000103	0.00243	CbGpPWpGaD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—ATM—melanoma	0.000102	0.00242	CbGpPWpGaD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CDK4—melanoma	0.000102	0.00241	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—NODAL—melanoma	0.000101	0.0024	CbGpPWpGaD
Sparfloxacin—ABCB1—HIF-1-alpha transcription factor network—EDN1—melanoma	0.000101	0.00238	CbGpPWpGaD
Sparfloxacin—TOP2A—Retinoblastoma (RB) in Cancer—MYC—melanoma	9.9e-05	0.00234	CbGpPWpGaD
Sparfloxacin—TOP2A—Circadian rythm related genes—CDK4—melanoma	9.78e-05	0.00232	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle, Mitotic—SKP2—melanoma	9.59e-05	0.00227	CbGpPWpGaD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—APC—melanoma	9.59e-05	0.00227	CbGpPWpGaD
Sparfloxacin—TOP2A—Circadian rythm related genes—NOS2—melanoma	9.5e-05	0.00225	CbGpPWpGaD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—EGF—melanoma	9.48e-05	0.00224	CbGpPWpGaD
Sparfloxacin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—melanoma	9.37e-05	0.00222	CbGpPWpGaD
Sparfloxacin—TOP2A—Mitotic G1-G1/S phases—CDKN1B—melanoma	9.1e-05	0.00216	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—MAP3K5—melanoma	9.02e-05	0.00214	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—CASP10—melanoma	9.02e-05	0.00214	CbGpPWpGaD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CASP8—melanoma	8.93e-05	0.00212	CbGpPWpGaD
Sparfloxacin—TOP2A—Circadian rythm related genes—PPARG—melanoma	8.88e-05	0.0021	CbGpPWpGaD
Sparfloxacin—ABCB1—Allograft Rejection—CD86—melanoma	8.79e-05	0.00208	CbGpPWpGaD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—IGF1—melanoma	8.78e-05	0.00208	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle, Mitotic—AURKA—melanoma	8.77e-05	0.00208	CbGpPWpGaD
Sparfloxacin—ABCB1—HIF-1-alpha transcription factor network—TERT—melanoma	8.77e-05	0.00208	CbGpPWpGaD
Sparfloxacin—TOP2A—Mitotic G1-G1/S phases—CCND1—melanoma	8.68e-05	0.00206	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle—MLH1—melanoma	8.67e-05	0.00205	CbGpPWpGaD
Sparfloxacin—ABCB1—Allograft Rejection—IL10—melanoma	8.62e-05	0.00204	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle—SKP2—melanoma	8.58e-05	0.00203	CbGpPWpGaD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MAP2K1—melanoma	8.48e-05	0.00201	CbGpPWpGaD
Sparfloxacin—TOP2A—Mitotic G1-G1/S phases—CDKN1A—melanoma	8.4e-05	0.00199	CbGpPWpGaD
Sparfloxacin—ABCB1—HIF-1-alpha transcription factor network—HIF1A—melanoma	8.39e-05	0.00199	CbGpPWpGaD
Sparfloxacin—ABCB1—Allograft Rejection—IL4—melanoma	8.38e-05	0.00199	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—DCC—melanoma	8.34e-05	0.00197	CbGpPWpGaD
Sparfloxacin—ABCB1—Allograft Rejection—PDGFRA—melanoma	8.25e-05	0.00195	CbGpPWpGaD
Sparfloxacin—ABCB1—Allograft Rejection—HLA-B—melanoma	8.2e-05	0.00194	CbGpPWpGaD
Sparfloxacin—TOP2A—Retinoblastoma (RB) in Cancer—TP53—melanoma	8.13e-05	0.00193	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—APAF1—melanoma	8.09e-05	0.00192	CbGpPWpGaD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—FGF2—melanoma	8.07e-05	0.00191	CbGpPWpGaD
Sparfloxacin—ABCB1—Allograft Rejection—FASLG—melanoma	8.01e-05	0.0019	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle—AURKA—melanoma	7.84e-05	0.00186	CbGpPWpGaD
Sparfloxacin—ABCB1—Allograft Rejection—FAS—melanoma	7.72e-05	0.00183	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—melanoma	7.67e-05	0.00182	CbGpPWpGaD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—BCL2—melanoma	7.66e-05	0.00182	CbGpPWpGaD
Sparfloxacin—ABCB1—HIF-1-alpha transcription factor network—NOS2—melanoma	7.63e-05	0.00181	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle, Mitotic—APEX1—melanoma	7.62e-05	0.0018	CbGpPWpGaD
Sparfloxacin—ABCB1—Allograft Rejection—HLA-A—melanoma	7.59e-05	0.0018	CbGpPWpGaD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MDM2—melanoma	7.55e-05	0.00179	CbGpPWpGaD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—ARL2—melanoma	7.53e-05	0.00178	CbGpPWpGaD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—ERBB2—melanoma	7.44e-05	0.00176	CbGpPWpGaD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PTGS2—melanoma	7.28e-05	0.00172	CbGpPWpGaD
Sparfloxacin—TOP2A—Mitotic G1-G1/S phases—MYC—melanoma	6.96e-05	0.00165	CbGpPWpGaD
Sparfloxacin—ABCB1—Allograft Rejection—HLA-DRB1—melanoma	6.94e-05	0.00164	CbGpPWpGaD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CDKN1B—melanoma	6.89e-05	0.00163	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle—APEX1—melanoma	6.81e-05	0.00161	CbGpPWpGaD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CASP3—melanoma	6.76e-05	0.0016	CbGpPWpGaD
Sparfloxacin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—melanoma	6.74e-05	0.0016	CbGpPWpGaD
Sparfloxacin—SLC22A5—Transmembrane transport of small molecules—SLC5A5—melanoma	6.63e-05	0.00157	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle, Mitotic—CDKN2B—melanoma	6.59e-05	0.00156	CbGpPWpGaD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CCND1—melanoma	6.58e-05	0.00156	CbGpPWpGaD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CTNNB1—melanoma	6.51e-05	0.00154	CbGpPWpGaD
Sparfloxacin—ABCB1—Allograft Rejection—CD80—melanoma	6.41e-05	0.00152	CbGpPWpGaD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CDKN1A—melanoma	6.36e-05	0.00151	CbGpPWpGaD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PTEN—melanoma	6.35e-05	0.0015	CbGpPWpGaD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—NFKB1—melanoma	6.32e-05	0.0015	CbGpPWpGaD
Sparfloxacin—SLC22A5—SLC-mediated transmembrane transport—ALB—melanoma	6.23e-05	0.00148	CbGpPWpGaD
Sparfloxacin—TOP2A—Circadian rythm related genes—PTEN—melanoma	6.09e-05	0.00144	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle, Mitotic—E2F1—melanoma	6.05e-05	0.00143	CbGpPWpGaD
Sparfloxacin—ABCB1—Allograft Rejection—CASP8—melanoma	5.96e-05	0.00141	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle, Mitotic—PRKCA—melanoma	5.93e-05	0.0014	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle—CDKN2B—melanoma	5.89e-05	0.0014	CbGpPWpGaD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—VEGFA—melanoma	5.73e-05	0.00136	CbGpPWpGaD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—SLC15A2—melanoma	5.71e-05	0.00135	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle, Mitotic—PCNA—melanoma	5.7e-05	0.00135	CbGpPWpGaD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—SLC17A5—melanoma	5.49e-05	0.0013	CbGpPWpGaD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MAPK3—melanoma	5.42e-05	0.00128	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle—E2F1—melanoma	5.41e-05	0.00128	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle—PRKCA—melanoma	5.3e-05	0.00126	CbGpPWpGaD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MYC—melanoma	5.28e-05	0.00125	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle, Mitotic—CDK2—melanoma	5.22e-05	0.00124	CbGpPWpGaD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MAPK1—melanoma	5.16e-05	0.00122	CbGpPWpGaD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—EGFR—melanoma	5.16e-05	0.00122	CbGpPWpGaD
Sparfloxacin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—melanoma	5.16e-05	0.00122	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle—PCNA—melanoma	5.1e-05	0.00121	CbGpPWpGaD
Sparfloxacin—ABCB1—Allograft Rejection—IFNG—melanoma	5.07e-05	0.0012	CbGpPWpGaD
Sparfloxacin—SLC22A5—Transmembrane transport of small molecules—ABCB1—melanoma	5.06e-05	0.0012	CbGpPWpGaD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—SLC6A11—melanoma	4.99e-05	0.00118	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle, Mitotic—CDK4—melanoma	4.93e-05	0.00117	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle—TERT—melanoma	4.93e-05	0.00117	CbGpPWpGaD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TNF—melanoma	4.91e-05	0.00116	CbGpPWpGaD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—KRAS—melanoma	4.87e-05	0.00115	CbGpPWpGaD
Sparfloxacin—ABCC2—Transmembrane transport of small molecules—SLC5A5—melanoma	4.85e-05	0.00115	CbGpPWpGaD
Sparfloxacin—ABCB1—Allograft Rejection—CXCL8—melanoma	4.71e-05	0.00112	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle—CDK2—melanoma	4.66e-05	0.0011	CbGpPWpGaD
Sparfloxacin—ABCB1—Allograft Rejection—CASP3—melanoma	4.51e-05	0.00107	CbGpPWpGaD
Sparfloxacin—ABCB1—Allograft Rejection—IL2—melanoma	4.5e-05	0.00107	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—melanoma	4.48e-05	0.00106	CbGpPWpGaD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PIK3CA—melanoma	4.48e-05	0.00106	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle—ATM—melanoma	4.43e-05	0.00105	CbGpPWpGaD
Sparfloxacin—ABCB1—HIF-1-alpha transcription factor network—VEGFA—melanoma	4.42e-05	0.00105	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle—CDK4—melanoma	4.41e-05	0.00104	CbGpPWpGaD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—melanoma	4.33e-05	0.00103	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle, Mitotic—RB1—melanoma	4.29e-05	0.00102	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—FGF1—melanoma	4.2e-05	0.000996	CbGpPWpGaD
Sparfloxacin—TOP2A—Circadian rythm related genes—TP53—melanoma	4.16e-05	0.000985	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—E2F1—melanoma	4.11e-05	0.000975	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—melanoma	4.07e-05	0.000964	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—PRKCA—melanoma	4.03e-05	0.000955	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—melanoma	3.95e-05	0.000936	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—melanoma	3.88e-05	0.000919	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—ACER3—melanoma	3.86e-05	0.000913	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle—RB1—melanoma	3.83e-05	0.000908	CbGpPWpGaD
Sparfloxacin—ABCB1—Allograft Rejection—VEGFA—melanoma	3.83e-05	0.000906	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—melanoma	3.81e-05	0.000903	CbGpPWpGaD
Sparfloxacin—TOP2A—Circadian rythm related genes—IL6—melanoma	3.81e-05	0.000902	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle, Mitotic—CDKN2A—melanoma	3.77e-05	0.000893	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—RAC1—melanoma	3.74e-05	0.000885	CbGpPWpGaD
Sparfloxacin—ABCC2—Transmembrane transport of small molecules—ABCB1—melanoma	3.7e-05	0.000876	CbGpPWpGaD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—AKT1—melanoma	3.66e-05	0.000867	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—CDK2—melanoma	3.55e-05	0.000841	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—UGT2B10—melanoma	3.53e-05	0.000835	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle—CDKN2A—melanoma	3.37e-05	0.000798	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—ATM—melanoma	3.37e-05	0.000798	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—melanoma	3.35e-05	0.000794	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle, Mitotic—CDKN1B—melanoma	3.34e-05	0.000791	CbGpPWpGaD
Sparfloxacin—ABCB1—Allograft Rejection—TNF—melanoma	3.28e-05	0.000777	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—HS3ST5—melanoma	3.28e-05	0.000776	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle—MDM2—melanoma	3.27e-05	0.000774	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle, Mitotic—CCND1—melanoma	3.18e-05	0.000754	CbGpPWpGaD
Sparfloxacin—SLC22A5—Transmembrane transport of small molecules—ALB—melanoma	3.16e-05	0.00075	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—APC—melanoma	3.16e-05	0.000748	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—EGF—melanoma	3.12e-05	0.000739	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle, Mitotic—CDKN1A—melanoma	3.08e-05	0.00073	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle—CDKN1B—melanoma	2.98e-05	0.000707	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—melanoma	2.94e-05	0.000696	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—melanoma	2.89e-05	0.000685	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle—CCND1—melanoma	2.85e-05	0.000674	CbGpPWpGaD
Sparfloxacin—ABCB1—HIF-1-alpha transcription factor network—AKT1—melanoma	2.82e-05	0.000668	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—MAP2K1—melanoma	2.79e-05	0.000662	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle—CDKN1A—melanoma	2.75e-05	0.000652	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—melanoma	2.66e-05	0.000629	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle, Mitotic—MAPK3—melanoma	2.63e-05	0.000622	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle, Mitotic—MYC—melanoma	2.55e-05	0.000605	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—melanoma	2.52e-05	0.000598	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle, Mitotic—MAPK1—melanoma	2.5e-05	0.000592	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—melanoma	2.49e-05	0.000589	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—PLCB4—melanoma	2.48e-05	0.000588	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—melanoma	2.45e-05	0.000581	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—melanoma	2.4e-05	0.000568	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle—MAPK3—melanoma	2.35e-05	0.000556	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—PIP4K2A—melanoma	2.34e-05	0.000553	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—SLC6A11—melanoma	2.34e-05	0.000553	CbGpPWpGaD
Sparfloxacin—ABCC2—Transmembrane transport of small molecules—ALB—melanoma	2.31e-05	0.000548	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle—MYC—melanoma	2.28e-05	0.000541	CbGpPWpGaD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—SLC5A5—melanoma	2.28e-05	0.00054	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—MTAP—melanoma	2.27e-05	0.000538	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—melanoma	2.27e-05	0.000538	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle—MAPK1—melanoma	2.23e-05	0.000529	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—melanoma	2.23e-05	0.000527	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—melanoma	2.17e-05	0.000513	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—melanoma	2.14e-05	0.000508	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—melanoma	2.1e-05	0.000496	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—melanoma	2.09e-05	0.000495	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—melanoma	2.08e-05	0.000493	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—LUM—melanoma	2.03e-05	0.00048	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—PHGDH—melanoma	2.03e-05	0.00048	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—HPSE—melanoma	1.99e-05	0.00047	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—CUBN—melanoma	1.95e-05	0.000462	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—melanoma	1.89e-05	0.000447	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—SDHD—melanoma	1.88e-05	0.000446	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—CSPG4—melanoma	1.88e-05	0.000446	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—BSG—melanoma	1.88e-05	0.000446	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle—TP53—melanoma	1.88e-05	0.000444	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—GPAM—melanoma	1.82e-05	0.000432	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—melanoma	1.79e-05	0.000423	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—melanoma	1.74e-05	0.000411	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—melanoma	1.7e-05	0.000403	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—melanoma	1.7e-05	0.000402	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—melanoma	1.62e-05	0.000383	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—melanoma	1.61e-05	0.00038	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—PLA2G6—melanoma	1.55e-05	0.000367	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—melanoma	1.47e-05	0.000349	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—melanoma	1.43e-05	0.000338	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—VCAN—melanoma	1.39e-05	0.00033	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—melanoma	1.2e-05	0.000285	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—CYP17A1—melanoma	1.18e-05	0.000278	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—GNA11—melanoma	1.11e-05	0.000263	CbGpPWpGaD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—ALB—melanoma	1.09e-05	0.000258	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—FASN—melanoma	1.09e-05	0.000257	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—SLC5A5—melanoma	1.07e-05	0.000253	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—GNAQ—melanoma	1.03e-05	0.000244	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—CD44—melanoma	1.03e-05	0.000244	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—CYP1B1—melanoma	9.89e-06	0.000234	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—PRKCA—melanoma	7.5e-06	0.000178	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—ERCC2—melanoma	7.43e-06	0.000176	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—PIK3CG—melanoma	5.87e-06	0.000139	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—PPARG—melanoma	5.67e-06	0.000134	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—PIK3CD—melanoma	5.16e-06	0.000122	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—ALB—melanoma	5.1e-06	0.000121	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—PIK3CB—melanoma	4.5e-06	0.000107	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—PTGS2—melanoma	4.46e-06	0.000106	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—PTEN—melanoma	3.89e-06	9.21e-05	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—PIK3CA—melanoma	2.74e-06	6.5e-05	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—AKT1—melanoma	2.24e-06	5.31e-05	CbGpPWpGaD
